4/16
07:10 am
clsd
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors [Yahoo! Finance]
Medium
Report
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors [Yahoo! Finance]
4/16
07:05 am
clsd
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
Medium
Report
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
4/11
08:06 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
4/2
07:07 am
clsd
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
High
Report
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
4/2
07:05 am
clsd
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
High
Report
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
3/18
03:10 pm
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
3/18
07:09 am
clsd
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer [Yahoo! Finance]
Medium
Report
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer [Yahoo! Finance]
3/18
07:05 am
clsd
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
Medium
Report
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
3/13
10:20 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $5.00.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $5.00.
3/13
08:54 am
clsd
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/12
04:15 pm
clsd
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/12
04:05 pm
clsd
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Medium
Report
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
3/6
02:36 pm
clsd
These 2 ‘Strong Buy' Penny Stocks Could Surge Over 200%, Say Analysts [Yahoo! Finance]
Medium
Report
These 2 ‘Strong Buy' Penny Stocks Could Surge Over 200%, Say Analysts [Yahoo! Finance]
2/29
07:05 am
clsd
Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024
Low
Report
Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024
2/10
01:03 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/9
06:17 am
clsd
Pleasing Signs As A Number Of Insiders Buy Clearside Biomedical Stock [Yahoo! Finance]
Low
Report
Pleasing Signs As A Number Of Insiders Buy Clearside Biomedical Stock [Yahoo! Finance]
2/7
08:10 am
clsd
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering [Yahoo! Finance]
Neutral
Report
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering [Yahoo! Finance]
2/7
08:00 am
clsd
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
Neutral
Report
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
2/2
01:07 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.